Join Rebecca Michael, Principal Group Leader, Early Development Services at Lonza Biologics to learn how in silico and in vitro design and optimization tools can help you not only assess but also mitigate risks and how to optimize early expression and material supply processes to enable optimal developability of your candidate. These activities are designed to ensure that early process development efforts are focused on key developability challenges to minimize scale-up risk. Case studies will illustrate how these activities maximize the chances of success of your development journey. 

You may also be interested in:
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center